Female sexuality

Medical Clinics of North America

Volumn 87, Issue 5, 2003, Pages 1077-1090

  Morley, John E ^a,b   Kaiser, Fran E ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE; SILDENAFIL; TESTOSTERONE; TIBOLONE;

AGING; ANAMNESIS; ANGINA PECTORIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISTRESS SYNDROME; DYSPAREUNIA; DYSPNEA; FATIGUE; FEMALE; HEART INFARCTION; HUMAN; LIBIDO; LIBIDO DISORDER; LIFESPAN; ORGASM; PAIN; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; SEXUALITY;

EID: 0242269825     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00102-0     Document Type: Review

References (55)

1. Bernhard LA. Sexuality and sexual health care for women. Clin Obstet Gynecol 2002;45:1089-98.
2. Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44.
3. Basson R, Berman JR, Burnett A, et al. Report on the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications. J Urol 2000;163:888-93.
4. Masters EH, Johnson VE. Human sexual response. Boston: Little Brown; 1966.
5. Sasson R. The female sexual response: a different model. J Sex Marital Ther 2000;26:51-65.
6. Munarriz R, Kim NN, Goldstein I, Traish AM. Biology of female sexual function. Urol Clin North Am 2002;29:685-93.
7. Xu B, Chibber R, Ruggerio D, Kohner E, Ritter J, Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J 2003;17:1289-91.
8. Paler MH, Fitzgerald S. Urinary incontinence in working women: a comparison study. J Womens Health 2002;11:879-88.
9. Goetsch MF. Postpartum dyspareunia: an unexplored problem. J Reprod Med 1999; 44:963-8.
10. Kaiser FE. Sexual function and the older cancer patient. Oncology 1992;6:112-9.
11. Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 2001;76:224-36.
12. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999;282:1934-41.
13. Siddiqi SU, Van Dyke DC, Donohue P, McBrien DM. Premature sexual development in individuals with neurodevelopmental disabilities. Dev Med Child Neurol 1999;41:392-5.
14. Ambler N, Williams AC, Hill P, Gunary R, Cratchley G. Sexual difficulties of chronic pain patients. Clin J Pain 2001;17:138-45.
15. Morley JE. Sexual function and the aging woman. In: Morley JE, Korenman SG, editors. Endocrinology and metabolism in the elderly. Boston: Blackwell Scientific Publications; 1992. p. 307-21.
16. Morley JE, Kaiser FE, Perry HM, et al. Longitudinal changes in testosterone, leuteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 1997;46:410-3.
17. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-31.
18. Morley JE. Andropause: Is it time for the geriatrician to treat it? J Gerontol Med Sci 2001;56A:M263-5.
19. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci 2002;57A:M76-99.
20. Morley JE, Perry HM. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med 2000;135:370-8.
21. Wittert GA, Chapman IM, Haren MT, MacKintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci 2003;58A:618-25.
22. Morley JE, Perry HM III. Androgens and women at the menopause and beyond. J Gerontol Med Sci 2003;58A:409-16.
23. Zumoff B, Strain GW, Miller LK, et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995;80:1429-30.
24. Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-8.
25. Dennerstein L, Smith A, Morse C, et al. Sexuality and the menopause. J Psychosom Obstet Gynecol 1994;15:56-9.
26. Bancroft J, Cawood EHH. Androgens and the menopause: a study of 40-60 year old women. Clin Endocrinol 1996;45:577-87.
27. Burger HG, Hailes J, Nelson J, et al. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. BMJ 1987;294:1936-7.
28. Sherwin BN, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in surgical menopause. Psychosom Med 1991;49:45-50.
29. Notelowitz M. Menopause. In: Endocrinology of aging. Morley JE, van den Berg L, editors. Totowa, NJ: Humana Press; 2000. p. 161-79.
30. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8.
31. Dobs AS, Nguyen T, Pace C, Roberts CP. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002;87:1509-16.
32. Davis SR, McCloud PI, Strauss BJG, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-36.
33. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol Med Sci 2002;57A:M772-7.
34. Kenny AM, Dawson L, Leppinger A, Iannuzzi-Sucich M, Judge JO. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J Gerontol Med Sci 2003;58A:436-40.
35. Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med 2001;137:231-43.
36. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci 2001;56:M146-56.
37. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol Med Sci 2002;57A:M698-704.
38. Bortz WM. A conceptual framework of frailty: a review. J Gerontol Med Sci 2002; 57A:M283-8.
39. Morales AJ, Nolan JJ. Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7.
40. Beaulieu EE, Thomas G, LeGrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A 2000;97:4279-84.
41. Villareal DT, Morley JE. Trophic factors in aging - should older people receive hormonal replacement therapy. Drugs Aging 1994;4:492-509.
42. Davis SR. The effects of tibolone on mood and libido. Menopause 2002;9:162-70.
43. Kokcu A, Cetinkaya MB, Yanik F, et al. The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women. Maturitas 2000;36:75-80.
44. Morris EP, Wilson POG, Robinson J, et al. Long term effects of tibolone on the genital tract in postmenopausal women. Br J Obstet Gynecol 1999;106:954-9.
45. Meeuwsen IB, Samson MM, Duursma SA, et al. The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. Endocrinology 2001;142:4813-7.
46. Pavlov PW, Ginsbrug J, Kocovic PM, et al. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures. Gynecol Endocrinol 1999;13:230-7.
47. Solarz AL. Lesbian health: current assessment and directions for the future. Washington: National Academy Press; 1999.
48. Annon JS. Behavioral treatment of sexual problems. San Francisco: Harper & Row; 1976.
49. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the brief index of sexual functioning for women. Arch Sex Behav 1994;23:627-43.
50. Derogatis LR. The Derogatis interview for sexual functioning (DISF/DISF-SR): an introductory report. J Sex Marital Ther 1997;23:291-304.
51. Rosen RC, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
52. Rosen RC, Meston C, Yalcin I, et al. The female sexual dysfunction diagnostic (FSDD): a standardized instrument for clinical assessment of FSAD [abstract]. Presented at the Female Sexual Function Forum. Boston, October 25-28, 2001.
53. Billips KL, Berman L, Berman J. A new non-pharmacological vacuum therapy for female sexual dysfunction. J Sex Marital Ther 2001;27:435-41.
54. Berman JR, Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001;28:405-16.
55. Rosen RC, Phillips NA, Gendrano N. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 1999;25:137-44.